Warren Buffett Grabs Some More Shares Of DaVita

As of September 28, 2012, Warren Buffett and Berkshire Hathaway Inc. have purchased another 282,403 shares of DaVita Inc. The total share price purchase for this transaction was $103.83 per share.

This brings the amount of shares that Berkshire Hathaway owns all way up to 9,582,403 shares. It’s also a 28% increase from the amount of shares that they reported owning on June 6. This makes Warren Buffett and Berkshire Hathaway currently a 10% owner in the company.

If you’re not aware of this already, DaVita Inc. actually delivers a dialysis service to those individuals suffering from chronic kidney failure, as well as end-stage renal disease. The service provides clinical care, as well as integrated treatment plans, health management services and teams that are capable of putting together personalized care. The company actually has 1800 centers for outpatient dialysis across the nation, as well as 19 other centers for dialysis outside of the United States of America in four different countries. We learned this information from the company’s website.

Other than the large purchase just made by Berkshire Hathaway, there was actually more insider activity going on at DaVita throughout this month. Pamela Arway, the DVA Director sold four thousand of her shares during September. David Shapiro, who is the DVA Chief Compliance Officer, sold over 15,000 of his shares. Leanne Zumwalt, DVA Group Vice President, sold over 4900 of her shares as well.

Some of the other big guns in the financial world that own shares of this company are as follows: Steve Mandel of Lone Pine Capital currently owns about 3.2% of the company. Andreas Halvorsen, from Viking Global Investors LP, owns roughly 3.34% of DVA. And last but not least, Lee Ainslie of Maverick Capital owns 0.73%.

The net income of DaVita is roughly $2.8 million, and we base this on the figures that the company reported this past June for their six-months quarterly report.

DaVita’s current P/E ratio is 17.3. Their P/S ratio is 1.4, and they have an annual earnings growth of 18.6% over the last 10 years. Their market cap is $9.8 billion. They are currently trading at their highest price in the last three years.

Leave a Reply

Your email address will not be published. Required fields are marked *